Landing Med's on-premise AI cervical cytology algorithm provides secure, offline, AI-powered analysis for cervical cytology diagnosis. Utilizing scanned WSIs from the LD Patho 320A or LD Cyto 2200 scanners, our robust AI algorithm, trained on over 10 million samples, autonomously processes and identifies areas of interest, streamlining physicians' workflow and enhancing accuracy in cervical AI cytology interpretation.
By operating entirely offline, our LD CytoBrain system ensures that all data remains securely on-site, eliminating cloud dependency and safeguarding patient privacy. This robust solution integrates seamlessly into laboratory environments, empowering healthcare providers with efficient, reliable, and secure diagnostic support for AI cervical cancer screening.
Landing Med is a comprehensive provider of AI cervical cancer screening solutions, offering an end-to-end AICCS platform that streamlines and enhances the entire screening process. From liquid-based cytology kits to slide preparation equipment, digital pathology slide scanners, and robust AI-assisted analysis, Landing Med empowers laboratories and healthcare providers with integrated, affordable and efficient screening tools. Our innovative Cyto AISCAN simplifies digital cytopathology workflows and improves diagnostic performance, ensuring high-quality care in AI cervical cancer screening solutions.
Sample Collection
Slide Preparation & Staining
Slide Scanning
AI Analysis
Pathologist Review
Digital Report Issuance
CN
